| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 4e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 6e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.32 | 7e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |